Form 8-K - Current report:
SEC Accession No. 0001493152-24-003611
Filing Date
2024-01-24
Accepted
2024-01-24 16:15:36
Documents
15
Period of Report
2024-01-24
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 50797
2 ex99-1.htm EX-99.1 26140
3 ex99-1_001.jpg GRAPHIC 2181
  Complete submission text file 0001493152-24-003611.txt   322825

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE lgst-20240124.xsd EX-101.SCH 4344
5 XBRL DEFINITION FILE lgst-20240124_def.xml EX-101.DEF 27507
6 XBRL LABEL FILE lgst-20240124_lab.xml EX-101.LAB 38250
7 XBRL PRESENTATION FILE lgst-20240124_pre.xml EX-101.PRE 26127
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7155
Mailing Address 767 THIRD AVENUE, 38TH FLOOR NEW YORK NY 10017
Business Address 767 THIRD AVENUE, 38TH FLOOR NEW YORK NY 10017 646-807-8832
Semper Paratus Acquisition Corp (Filer) CIK: 0001860871 (see all company filings)

EIN.: 981597194 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41002 | Film No.: 24556600
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)